U.S. President Donald Trump announced plans on Tuesday to enforce a ‘25% or higher’ tariff on imports of semiconductors and pharmaceuticals, a decision likely to challenge India’s pharmaceutical sector. India’s generic drug manufacturers, who predominantly export to the United States, face uncertainty as their largest market hangs in the balance.
About the Author
